Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Godet

Showing results (651-660 of 689) with videos related to

Pageof 69
Sort By:
Cancer Immunology Research|May 31, 2024
Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T CellsMaxime Fredon, Margaux Poussard, Sabeha Biichlé, et al.
Nature|November 3, 2022
Extracellular fluid viscosity enhances cell migration and cancer disseminationKaustav Bera, Alexander Kiepas, Inês Godet, et al.
Cancer Immunology Research|October 20, 2025
Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer ImmunotherapyMyriam Ben Khelil, Maxime Fredon, Nawfel Adib, et al.
Cancer Research|May 20, 2016
Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell ImmunityLaurent Beziaud, Laura Mansi, Patrice Ravel, et al.
Frontiers in Plant Science|February 17, 2018
Latitudinal Patterns in European Seagrass Carbon Reserves: Influence of Seasonal Fluctuations versus Short-Term Stress and Disturbance EventsLaura M Soissons, Eeke P Haanstra, Marieke M van Katwijk, et al.
Open Forum Infectious Diseases|January 14, 2026
Compassionate Use of Olorofim for Invasive Mold Infections: A Nationwide Observational Study in FranceV Esnault, C Godet, D Garcia-Hermoso, et al.
Ejhaem|February 2, 2026
Teclistamab in Elderly Patients With Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis of the French RetrosTECtive CohortA Coste, S Godet, S Manier, et al.
BMJ (Clinical Research Ed.)|June 3, 2021
Effect of dexamethasone on complications or all cause mortality after major non-cardiac surgery: multicentre, double blind, randomised controlled trialKarim Asehnoune, Charlene Le Moal, Gilles Lebuffe, et al.
Intensive Care Medicine|October 4, 2021
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trialPierre-François Laterre, Peter Pickkers, Gernot Marx, et al.
Cell Reports|February 13, 2026
Hypoxia restores the acidosis-induced inhibition of cancer cell disseminationSe Jong Lee, Alice Amitrano, Qinling Yuan, et al.
Pageof 69

Showing results (651-660 of 689) with videos related to

Sort By:
Pageof 69
Cancer Immunology Research|May 31, 2024
Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T CellsMaxime Fredon, Margaux Poussard, Sabeha Biichlé, et al.
Nature|November 3, 2022
Extracellular fluid viscosity enhances cell migration and cancer disseminationKaustav Bera, Alexander Kiepas, Inês Godet, et al.
Cancer Immunology Research|October 20, 2025
Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer ImmunotherapyMyriam Ben Khelil, Maxime Fredon, Nawfel Adib, et al.
Cancer Research|May 20, 2016
Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell ImmunityLaurent Beziaud, Laura Mansi, Patrice Ravel, et al.
Frontiers in Plant Science|February 17, 2018
Latitudinal Patterns in European Seagrass Carbon Reserves: Influence of Seasonal Fluctuations versus Short-Term Stress and Disturbance EventsLaura M Soissons, Eeke P Haanstra, Marieke M van Katwijk, et al.
Open Forum Infectious Diseases|January 14, 2026
Compassionate Use of Olorofim for Invasive Mold Infections: A Nationwide Observational Study in FranceV Esnault, C Godet, D Garcia-Hermoso, et al.
Ejhaem|February 2, 2026
Teclistamab in Elderly Patients With Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis of the French RetrosTECtive CohortA Coste, S Godet, S Manier, et al.
BMJ (Clinical Research Ed.)|June 3, 2021
Effect of dexamethasone on complications or all cause mortality after major non-cardiac surgery: multicentre, double blind, randomised controlled trialKarim Asehnoune, Charlene Le Moal, Gilles Lebuffe, et al.
Intensive Care Medicine|October 4, 2021
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trialPierre-François Laterre, Peter Pickkers, Gernot Marx, et al.
Cell Reports|February 13, 2026
Hypoxia restores the acidosis-induced inhibition of cancer cell disseminationSe Jong Lee, Alice Amitrano, Qinling Yuan, et al.
Pageof 69